Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes how he helps his EGFR lung cancer patients make decisions about next steps in treatment...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes how he helps his EGFR lung cancer patients make decisions about next steps in treatment...
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what...
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what...
"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes...
Hello I have STAGE IV nsclc adenocarcinoma, KRAS type limited to my lungs I was diagnosed 2 years ago and had a left pneumonectomy for extensive...
Hello. I am a esophageal cancer patient (2007) who is ten years out with a re-occurrance to my lower left lobe in 2014 (chemo 2014 and surgery Jan...
My 58 year husband had a history of Barrett’s disease and following a routine endoscopy, was diagnosed with esophageal cancer. Following a PET/CT scan...
Hi -- I have NSCLC (stage 4) with mets to spine and brain. I have been on Tagrisso for 4.5 months after progressing on Tarceva after 6-12 mos. My last...
Hi everyone, My father, age 70, was diagnosed with NSCLC on 10/02/17. EGFR and ALK negative. Brain MRI and bone scan clear. Yesterday’s CT scan showed...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.